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Abstract
Background: Meningitis still accounts for many deaths in children especially during epidemics in countries within the 
African meningitis belt. Between February and May 2012, the Gambia witnessed an outbreak of meningitis in two of its six 
regions. This study presents a clinical perspective of this outbreak in central river region of the Gambia. It evaluated the 
outbreak pattern, clinical features, and mortality among suspected cases that presented to the hospital during the outbreak.
Methodology: This is a prospective observational study of suspected cases of meningitis that presented to the pediatric 
ward of the Bansang Hospital during the outbreak period. Confirmed cases of meningitis were consecutively enrolled, and 
those with negative blood cultures presenting during the same period were employed as controls.
Result: Two hundred and four suspected cases of meningitis presented to the pediatric ward during the outbreak. Ninety 
were confirmed as meningitis cases. The W135 strain of Neisseria meningitidis was responsible for 89 (98.9%) of meningitis 
cases seen with an incidence rate of 74.9/100,000 in children (0-14 years) and in-hospital case fatality rate of 7.9%. Highest 
attack rate was among the 12-49 months age group. Clinical features such as meningeal signs (neck stiffness), conjunctivitis, 
and joint swelling were seen more in cases than controls. Contact history with relatives, who had fever in previous 2 weeks 
prior to illness was significantly seen more in cases. Adjusted regression analysis showed 7.5 more likelihood of infection 
with positive contact history (odds ratio [OR]: 7.2 confidence interval [CI]: [3.39-15.73]). There was no significant difference 
in death outcome between cases and controls (OR: 0.78 CI: [0.29-2.13]). The double peak wave-like pattern of the epidemic 
curve noted during this outbreak suggests a disseminated outbreak originating from an index case with propagated spread.
Conclusion: There is need for more effective surveillance and incorporation of vaccine against meningitis into the expanded 
program on immunization schedule of the Gambia and other countries within the meningitic epidemic belt.
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Introduction
Neisseria meningitidis is a known cause of deaths and 
neurological sequela worldwide. The effect is particularly 
pronounced in Africa where malnutrition and other infective 
disease are prevalent. In 1997 alone, 1390 confirmed cases 
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and 220 deaths were recorded in an outbreak that occurred 
in the upper river region (URR) of the Gambia.[1] Due to 
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the rapid onset, high‑case fatality rate and neurological 
sequela, a single case constitutes an outbreak and requires 
a rapid, well‑organized public health response which can 
include antibiotics or vaccination for all residents of those 
areas, especially those who are/were in close contact with 
an infected person. Since World War II, such epidemics 
have been rare in industrialized countries, but they occur 
periodically in the African meningitis belt and in China.[2‑7] 
The African meningitis belt extends from Ethiopia in the 
East, to Senegal in the West within the range of 300‑
1100 mm annual rainfall. Periodic infections occur in 
seasonal and annual cycles, while large‑scale epidemics occur 
at greater intervals with irregular patterns in this region.
In countries within the meningitis belt, the estimated 
incidence for the 20 years period 1970‑1992 was about 
800,000 cases.[2] The underlying mechanisms leading to the 
spread of meningococci and to epidemics of meningococcal 
disease remain unknown. Carriage rates of 15% can occur 
during epidemics in Africa.[8,9] The extreme environmental 
conditions present in the sub‑Saharan meningitis belt during 
the dry season namely high temperature, low absolute 
humidity, and the harmattan (a dusty wind that blows from 
the Sahara) – plus respiratory co‑infections due to damage to 
the mucosal defenses are thought to contribute to enhanced 
susceptibility to meningococcal disease.[10]
Between February and May 2012, 10 countries namely 
Benin, Burkina Faso, Chad, Central African Republic, Côte 
d’Ivoire, Gambia, Ghana, Mali, Nigeria, and Sudan reported 
a total of 11,647 meningitis cases including 960 deaths 
resulting in a case fatality ratio of 8.2%. The outbreaks were 
mainly caused by the W135 sero‑group of N. meningitidis 
bacteria.[11] In the Gambia, the outbreak occurred mostly 
in two of its six region as already described in the paper 
titled ‑  Sero‑group W135 meningococcal disease, The 
Gambia.[12] This study describes the outbreak of meningitis 
in the Central River Region (CRR), which was one of the 
two regions affected and evaluated the outbreak pattern, 
clinical features and mortality in infected children that 
presented to the Pediatric section of Bansang Hospital.
Methodology
Study area
The CRR is one of the six regions in The Gambia [Figure 1]. 
It is divided into North and South banks by the river Gambia 
with its administrative headquarters in Janjangbureh. The 
region has an area of about 48,000 km2. It shares border with 
the republic of Senegal on the North and the Southern part 
and Cassamance to the West. Internally, it is bordered by the 
Lower River Region (LRR) and Upper River Region (URR) 
to the West and East, respectively. The 2012 projected 
population of CRR is 256,990 out of which 120,100 (46.7%) 
are children 14 years and below.[13] There are 692 villages 
located within 11 districts.[13] The region has 17 primary 
health care centers, 8 public health facilities, 2 NGO clinics, 
and one general hospital located in Bansang.[13] The Bansang 
Hospital, which is the largest serves as referral center in the 
region and provides a higher standard of maternal and child 
health care services compared with other health facilities 
within the region.[13]
Study technique and subject
This is a prospective observational study. Routine surveillance 
by the pneumococcal surveillance project of the Medical 
Research Council (MRC) for invasive pneumococcal disease 
is on‑going in the region. Blood culture and/or diagnostic 
lumbar puncture when indicated are performed on suspected 
cases of sepsis, pneumonia, and meningitis based on study 
criteria[14] in children under‑five presenting to the Bansang 
Hospital. However, during the meningitis outbreak blood 
culture and/or lumbar puncture was done for all patients 
with suspected meningitis presenting to the pediatric ward 
of the hospital.
Standard case definition
•   Suspected  case  of  acute meningitis was  defined  as 
onset of fever (>38.5°C rectal or 38.0°C auxiliary) 
with a stiff neck (in children above 1 year of age) or 
bulging fontanelle (in children below 1 year of age) 
with or without convulsion[15]
•   Confirmed  case  of  acute meningitis  is  a  suspected 
as defined above with either positive cerebrospinal 
fluid (CSF) antigen detection for bacterial OR 
a positive culture of CSF for bacterial organism AND/
OR positive blood culture with identification of 
N. meningitidis.[15]
Data collection
Apart from those presenting to the hospital, suspected cases 
were also identified by active surveillance carried out in all 
Figure 1: Six regions of the Gambia (study area is colored purple)
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districts of the CRR by a joint public health team of the 
regional health authority and the MRC. The public health 
team was sent to villages were confirmed meningitis cases had 
been identified and residents of those villages were informed 
about the meningitis outbreak. Signs and symptoms of 
meningitis were explained and the village residents were asked 
to take any child with similar presentation to the hospital for 
treatment. Furthermore, public enlightenment via radio was 
done throughout the CRR during the outbreak period. Health 
officer incharge in other health facilities in the region were 
requested to refer all suspected cases to Bansang Hospital for 
proper evaluation and management.
Based on the pneumococcal surveillance study criteria,[14] 
X‑ray was done for all patients with suspected pneumonia. 
Suspected pneumonia was defined as a history of cough or 
difficulty breathing for <14 days, accompanied by one or 
more of the following: Raised respiratory rate for age, lower 
chest wall in drawing, nasal flaring or grunting, oxygen 
saturation <92%, and focal chest signs (dull percussion 
note, coarse crackles, and bronchial breathing). Raised 
respiratory rate for age is defined as rates >60 breaths/min 
for children <2 months of age, >50 breaths/min for children 
aged 2‑11 months and >40 breaths/min for children aged 
12‑59 months.[14] X‑ray reading was done by clinician trained 
using the World Health Organization guidelines for diagnosis 
of radiological pneumonia.[16] For patients who presented 
with associated discharge and/or redness of the eye, vision 
was assessed using simple confrontational test due to lack of 
the Snerllen chart.
Suspected cases of meningitis had diagnostic lumbar 
puncture done in the sterile procedure room of the Bansang 
Hospital under aseptic conditions by study clinicians. The 
samples were sent within 1 hour of collection to the MRC 
regional laboratory in Basse. Cases were consecutively 
enrolled from February 1st to May 31st 2012 during the 
outbreak period. During enrolment, trained research nurses 
collected information about onset of illness, history of 
travel or contact with anyone with fever or travel history 
in the preceding 2 weeks, and immunization history 
where relevant.[17] Also, sex, age, weight, and height of 
cases were also documented. Malaria antigen test and 
hemoglobin level were done for all suspected cases. For 
every confirmed meningitis case, patients admitted during 
the same period with a negative blood culture results was 
enrolled as control and matched with cases on age and sex. 
Just like for cases, information on immunization, travel and 
contact history, weight, and height were also obtained for 
controls. Admission of patients into the ward was done by 
medical officers stationed at the outpatient and children 
emergency sections. Study clinicians were not in any way 
involved in admission of patients. Daily temperature and 
rainfall readings for the period of the outbreak (i.e. February, 
March, April May, and June 2012) were obtained from the 
hydro‑meteorological Department of the Ministry of Water 
Resources, Upper River Regional Office.[18]
Study specimen and laboratory investigation
Blood sample
Appropriate volume of blood as described in pneumococcal 
surveillance program (PSP), standard operating 
procedures[14] were collected from study patients suspected 
of having either pneumonia, sepsis, or meningitis 
inoculated into Bactec fluid medium, were incubated into 
the (Becton 9050, Beckton Dickinson, Erembodegem, 
Belgium). Antigen test was performed directly on the 
supernatant of the positive Bactec blood culture after 
boiling and centrifuging. Sero‑grouping was achieved using 
(Becton Dickinson, Erembodegem, Belgium). Sensitivity 
and specificity for this kit on serum for N. meningitidis W135 
is 98.5% and 100%, respectively.[19]
Cerebrospinal fluid samples
These samples were processed for Gram‑stain reaction and 
for leukocytes (neutrophils and lymphocytes). Cell count 
was done on all samples using improved Neubauer counting 
chamber by multiplying the number of white cells in four 
large squares by 2.5 × 106/L. Culture performed as indicated 
above. Antigen detection test was performed on boiled CSF 
aliquot with the use of BD‑Directigen Combo Test (cat in 
number 252360) following the manufacturer instruction.[19]
Ethical clearance
This study was done as part of the PSP for which prior ethical 
clearance had been obtained.[14] In addition, to this the 
ethical committees of the hospital management and regional 
health authority approved this study. Furthermore, verbal 
and written informed consent were also obtained from the 
parents and/or the care givers of all study participants before 
enrolment and performing any invasive procedure.
Data analysis
 Data was analyzed using IBM® SPSS version 20.0 (SPSS 
Inc, Chicago, IL) 
Distribution of study variables were computed and tabulated 
using frequency table. Comparison of these variables between 
cases and controls was assessed using Chi‑squares. Results 
were presented using percentages, odds ratio, (OR) and 
95% confidence intervals (CIs) were appropriate. Bivariate 
logistic was used to estimate association between identified 
factors and outcome in cases and controls. For all statistical 
tests performed, it was ensured that the assumptions 
for carrying out these specific tests were met. Statistical 
significance was set at P < 0.05.
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Results
Between February 1 and May 31, 2012, 204 suspected cases of 
meningitis were admitted to Bansang Hospital and 90 (44.1%) 
were confirmed cases of meningitis. Eighty‑nine (98.9%) of 
the confirmed cases had the W135 strain of N. meningitidis 
isolated from either CSF, blood, or both. Streptococcus 
pneumonia was cultured in the CSF of one of the cases.
Characteristic of study subjects
Seventy‑nine (88.8%) of the confirmed cases were children 
under 5 years of age [Table 1] with the highest attack rate in 
early school aged 12‑49 months. The age range of cases was 
1 month‑14 years, mean age of 34.9 months and bimodal 
ages of 12 and 36 months. The male:female ratio of cases was 
1.5:1 compared to 1.3:1 for controls (P = 0.646). None of 
the children has had any form of meningitis immunization. 
The history of other routine vaccination was complete for 
age in 47.2% of the cases and 45.7% of controls (P = 0.832).
About 6.7% of the cases had a positive malaria antigen 
test compared to 10.5% in controls (P = 0.347). Normal 
hemoglobin concentration was seen in 31.6% of cases and 
32.5% of controls (P = 0.880). The mean hemoglobin 
concentration of cases versus controls stratified by age 
was 15.7 versus 13.76 ± 2.80 (P = 0.616) in the neonatal 
age group, 10.33 ± 1.74 versus 10.0 ± 2.08 (P = 0.613) 
for the infant age group and 9.92 ± 2.28 versus 
10.30 ± 2.66 (P = 0.383) for the 12–59 months age group. 
Thirty‑six (40.5%) of the cases compared with 9 (7.9%) of 
control had contact with persons with fever in the preceding 
2 weeks of illness (P = 0.001). Adjusted logistic regression 
showed that patients with positive history of contact were 
7 times more likely to acquire N. meningitidis compared 
to those without positive history of contact (OR: 7.2, CI: 
3.39‑15.73). Similarly, 22.4% of cases compared to about 
25.4% of control had traveled or lived with relatives who 
had travelled outside place of residence 2 weeks prior to 
current illness (P = 0.624).
Clinical findings in study participants
Some of the clinical presentations of cases versus controls are 
shown in Table 2 below. Nonspecific clinical features such as 
vomiting, malaise, restlessness, feed refusal, diarrhea etc., were 
not included in the analysis. Joint affectation (P = 0.001), 
meningism (P = 0.001), and conjunctivitis (P = 0.002) 
were seen significantly more in cases than controls. All joint 
swelling seen during the study were in children <5 years of 
age. The wrist, knee, and ankle were most affected. The joints 
affectation was bilateral and tender. No joint tap was done 
because most mothers did not give consent for the procedure. 
Two controls had similar swelling and both were also bilateral 
and in children below 5 years of age. The presentation of 
conjunctivitis was characterized by bilateral thick conjunctiva 
redness that was itchy, purulent/clear sticky eye discharge 
with no apparent visual disturbance. All cases of eye redness 
developed after cases became ill. Seven of the nine cases were 
from different households, while two were siblings. Eight of the 
cases were under 5 years and one was about 7 years old. There 
was no history of contact with any person with conjunctivitis 
in the family or immediate vicinity in all nine patients. Eye 
swab yielded no growth in all cases. The conjunctivitis did 
not resolve in any of the cases while still on admission. None 
returned for follow‑up.
Table 1: Characteristics of study subject








Complete for age 42 (47.2) 52 (45.7) 0.823
Incomplete for age 47 (52.8) 62 (54.3)
Malaria parasite†2
Positive 6 (6.7) 12 (10.5) 0.347
Negative 83 (93.3) 102 (89.5)
Hemoglobin†3
Normal 28 (31.6) 37 (32.5) 0.880
Low 61 (68.4) 77 (67.5)
X-ray findings†4
Normal X-ray 32 (82.1) 45 (88.2) 0.408
End point and/or Non end 
point consolidation
7 (21.9) 6 (11.8)
Contact in preceding 2 weeks 
of illness with person with
Fever 36 (40.5) 9 (7.9) 0.001
Travel outside region 20 (22.4) 29 (25.4) 0.624
Outcome
Died 7 (7.9) 13 (11.4) 0.401
Discharged alive 82 (92.1) 101 (88.6)
†1Based on EPI schedule in the Gambia Health Ministry; †2Rapid diagnostic 
test based on antigen detection; †3World Health Organization definition 
of normal Hb levels based on age and sex; †4X‑ray reading based on World 
Health Organization guidelines. EPI=Expanded Program on Immunization








Fever 84 (94.4) 104 (96.3) 0.394
Cough 39 (43.9) 51 (47.2) 0.896
Convulsion 17 (19.1) 11 (10.2) 0.052
Joint swelling†1 15 (16.9) 2 (1.9) 0.000†2
Skin infection 11 (12.4) 8 (7.4) 0.195
Petechial hemorrhage 1 (1.1) 0 (0.0) 0.901
Meningism 71 (79.8) 1 (0.9) 0.000†2
Conjunctivitis 9 (10.1) 0 (0.0) 0.002†2
†1Joint affected were knee, wrist, and ankle joint; †2Statistically significant
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Characteristics of the outbreak
Between February and May 2012 over a period of 17 weeks, 
about 204 suspected cases of meningitis presented to the 
pediatric ward of the Bansang Hospital. The outbreak 
had a double peak period in weeks 5 and 8 during which 
the epidemic threshold of 10 cases/100,000/week[16] was 
exceeded [Figure 2]. There was a sharp decline in cases in the 
9th week of the outbreak and the decline continued gradually 
until the 12th week. After the 12th week, incidence rate 
became constant all through to the 15th week. No new cases 
were seen on weeks 16 and 17 during which the epidemic was 
declared over.[16] However, within the postepidemic period 
few new cases were identified in weeks 18, 19, 20, and 21 of 
June 2012. No vaccination campaign was done during the 
outbreak period due nonavailability of the meningococcal 
sero‑group W135 polysaccharide vaccine in the country.
Analysis of the temperature and rainfall readings during the 
outbreak periods showed that the rainfall was lowest during 
the outbreak period and recorded temperature readings were 
relatively high during the outbreak period [Figure 3].
Incidence was reported from all health district of 
the CRR with highest concentration in Jahanka and 
Cassamance which are border villages. The overall 
incidence rate of W135 meningitis during the outbreak 
in children 0‑14 years was 74.9/100,000 population. 
Cases were managed with antibiotics based on sensitivity 
results. Majority of the patient had chloramphenicol or 
ceftriaxone with adjuvant therapy like dexamethasone 
and mannitol. The average time of presentation was 
3‑4 and 1‑2 days before and after the region wide public 
enlightenment campaign, respectively. The average 
stay in hospital was 7 days (partly due to high patient 
load and lack of admitting bed spaces) and in‑hospital 
case fatality among patients with confirmed meningitis 
during outbreak period was 7.9% (7/89) compared to 
12.1% (13/114) for controls (P = 0.401). There was no 
significant difference in likelihood of death between cases 
versus controls (OR = 0.78 CI: [0.29‑2.13]). Nationwide 
vaccination using group ACYW135 meningococcal 
polysaccharide vaccine (manufactured by Zhejiang 
Tianyuan Bio‑Pharmaceutical Company Limited, Lot 
No. 201111009–2) was done 6 weeks after the outbreak.
Discussion
The meningitis outbreak occurred from February to May 
2012. These months were the hottest period of the year 
with very low humidity which is a well‑documented 
predisposition to meningitis outbreak.[10] The finding 
of the study has shown that contact with persons with 
fever (probably an undiagnosed case) was a significant 
risk factor for acquiring and transmitting the meningitis 
infection. As expected, clinical features peculiar to 
meningitis were significantly higher in cases while the 
nonspecific features were not significantly different between 
both groups. The findings of clinical presentations such as 
fever, neck stiffness, and convulsion are well documented 
in similar outbreaks which occurred in Burkina‑Faso[20] 
and Camerooun[21] but unlike these studies joint swelling 
and conjunctivitis were seen in significant number of cases 
during this outbreak.
Conjunctivitis caused by N. meningitidis could be 
concomitant with the systemic meningococcal infection, or 
in isolation as primary meningococcal conjunctivitis.[22‑24] 
On average, 10–17% of patients with primary meningococcal 
conjunctivitis may develop systemic disease, it is, therefore, 
important to establish a definitive diagnosis in all cases 
of conjunctivitis[25] especially in children who can readily 
transmit the infection to other children in schools and play 
areas. Whether the cases of conjunctivitis in this study were 
a co‑infection with other organisms like chlamydia[26] or 
other Neisseria spp. such as Neisseira gonorrhoea,[26] Neisseira 
ovis,[27] or Neisseira cinea[28] known to cause conjunctivitis 
or an uncommon presentation of the W135 strain is not 
clear. While meningitis can cause joint swelling as part of 
meningococcal septicemia during infection it is, however, 
not a common presentation of N. meningitis. In a study[29] 
in Taiwan in 2006, where the clinical symptoms of different 
strains of N. meningitidis were analyzed in 115 confirmed 
cases over a 3 years period, athralgia and arthritis were seen 
in 6 and 20 cases of W135 strain and non‑W135 strain, 
respectively. In the same study,[29] pneumonia, was also seen 
Figure 2: Epidemic curve during outbreak
Figure 3: Temperature and rainfall readings in relation to 
outbreaks epidemic curve
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in a significantly higher number of cases in patient whose 
meningitis was caused by W135 strain compared to those 
caused by non‑W135 strain. In similar, meningitis outbreaks 
in northern part of Nigeria in 1998 and 2007, allergic 
presentation like arthritis was also documented in some of 
the confirmed cases[30‑32] though the identified strains were 
not mentioned. Whether these presentations (arthritis 
and conjunctivitis) seen in this study are due to allergic 
reactions in cases, co‑infectivity or a rapidly emerging 
feature of the W135 strain of N. meningitidis is unknown. 
Studies focusing on clinical presentation in future outbreak 
will be needed to answer these questions.
The epidemic curve during the outbreak showed a pattern 
of case detection with an initial slow and progressive 
infection, and case detection which gradually builds up to a 
peak followed by a brief fall that rapidly builds up again into 
another peak of infection and case detection. The infection 
and case detection, then slowly tapers off until the outbreak 
was declared over. This double peak wave‑like pattern of 
epidemic curve noted strongly suggested a disseminated 
outbreak originating from an index case with propagated 
spread.[33]
The in‑hospital case fatality (7.9%) during the outbreak 
period seen in this analysis was slightly less but not 
significantly different from the average case fatality of 
8.2% reported from 42 districts of the 10 countries in the 
African meningitis belt which reported[11] a total of 960 
deaths from 11,647 confirmed cases within the same period. 
The number of deaths recorded in all affected countries 
was far lower than the 5352 deaths recorded in similar 
outbreak which occurred in 2009.[34] This may have been 
due to the rapid response to the outbreaks by the Ministries 
of Health of the various countries in collaboration with 
International Coordination Group (ICG) that implemented 
a series of preventive and control measures which 
included enhancement of surveillance, case management, 
sensitization of the population, strengthening of cross 
border collaboration, and provision of vaccines.[11] The ICG 
released a total of 11,000 vials of antibiotic (ceftriaxone) 
and 1,665,673 doses of vaccines to six countries namely 
Ghana, Sudan, Ivory Coast, Chad, Burkina Faso, and Benin 
most affected by the epidemic.[11] This is in addition to 
vaccines released with the support of Global Alliance for 
Vaccines and Immunization. The impact of the prompt 
action of these international agencies together with the 
ministry of health in these countries further stresses 
the need for global partnership as well as coordinated 
surveillance and management system at the national level 
for effective control of spread and mortality from meningitis 
during outbreaks.
Limitation
Despite the community wide campaign done during the 
outbreak advising community residents in the region to 
immediately take any ill child within their households to 
the hospital for assessment, being a hospital‑based study, the 
incidence rate that was calculated based on its findings may not 
be a true reflection of the incidence rate of the disease in the 
region during the outbreak. Secondly, the contacts mentioned 
in this survey were either compound or household contacts that 
had fever within 2 weeks preceding the study subject’s illness 
and presentation to the hospital. Due to logistic reasons, these 
contacts were not followed‑up to ascertain a definite diagnosis 
of the cause of their febrile illnesses.
Conclusion
This study highlights uncommon clinical features and the 
contagious nature of the W135 strain of the N. meningitidis 
during epidemic in children. It also shows how fast a single 
unidentified case can be disseminated very quickly in the 
community. Therefore, during an epidemic, all ill patients 
within the community irrespective of the symptoms should 
be encouraged to present to the hospital for review and the 
confirmed cases isolated and treated in the hospital to curtail 
transmission. Government through the appropriate units 
within the health ministry should as a yearly routine by radio 
announcement and public health campaigns remind and 
prepare communities during predisposing (i.e. hot windy with 
very low humidity) climatic conditions to have high index of 
suspicion for suspected cases and seek prompt hospital care. 
Immunization campaigns should also target these high risk 
periods and border communities. These measures will further 
reduce mortality during future outbreaks of meningitis which 
was significantly lower relative to previous outbreaks in the 
region mainly due to surveillance activity and prompt action 
by the ICG.
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